The Ohio State University | Strategic Alliance Partners

Latest from The Ohio State University

Leukemia/Lymphoma: Chaired by Narendranath Epperla, MD, MS

December 16, 2020

Video

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of leukemias and lymphomas.

Dr. Pawlik on Advances in Management of mCRC With Liver Metastases

December 09, 2020

Video

Timothy M. Pawlik, MD, PhD, MPH, discusses advances in the management of patients with metastatic colorectal cancer with liver metastases.

Dr. Bhat on ELEVATE-TN Results in Treatment-Naïve CLL

October 21, 2020

Video

Seema A. Bhat, MD, discusses the results of the phase 3 ELEVATE-TN trial in patients with treatment-naïve CLL.

Dr. Bhat on the FDA Approval of Acalabrutinib in CLL

October 19, 2020

Video

Seema A. Bhat, MD, discusses the approval of acalabrutinib in chronic lymphocytic leukemia based on data from the phase 3 ELEVATE-TN trial.

Dr. Bhat on the Potential for Time-Limited Combinations in CLL

October 15, 2020

Video

Seema A. Bhat, MD, discusses the potential for time-limited combination regimens in chronic lymphocytic leukemia.

Targeted Therapies Take Center Stage in the CLL Treatment Paradigm

October 14, 2020

Article

Seema A. Bhat, MD, spotlights the advances that have been made with BTK inhibitors in chronic lymphocytic leukemia, shares emerging approaches under exploration, and forecasts where the field is headed.